Preferred Name | Galantamine | |
Synonyms |
Galantamin 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl- Galanthamine Reminyl Nivaline Razadyne Lycoremine Galanthamine Hydrobromide Nivalin |
|
Definitions |
A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders. Name of the FDA approved preparation from J&J. |
|
ID |
http://purl.bioontology.org/ontology/MESH/D005702 |
|
altLabel |
Galantamin 6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl- Galanthamine Reminyl Nivaline Razadyne Lycoremine Galanthamine Hydrobromide Nivalin |
|
AQL |
AA AD AE AG AI AN BI BL CF CH CL CS EC GE HI IM IP ME PD PH PK PO RE SD ST TO TU UR |
|
cui |
C0028221 C0939465 C0016967 C0949312 |
|
DC |
1 |
|
definition |
A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders. Name of the FDA approved preparation from J&J. |
|
DX |
20040101 |
|
HN |
2004(1999) |
|
Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000502 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000235 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
Inverse of RB |
MJ4PTD2VVW 1953-04-4 0D3Q044KCA 0 |
|
isa |
http://purl.bioontology.org/ontology/MESH/D018697 |
|
LT |
TRD |
|
Machine permutation |
2004; see GALANTHAMINE 1999-2003;RAZADYNE was indexed under GALANTAMINE 2006-2009 |
|
Mapped from |
http://purl.bioontology.org/ontology/MESH/C473199 http://purl.bioontology.org/ontology/MESH/C048309 http://purl.bioontology.org/ontology/MESH/C013604 http://purl.bioontology.org/ontology/MESH/C548757 http://purl.bioontology.org/ontology/MESH/C000729570 http://purl.bioontology.org/ontology/MESH/C050211 http://purl.bioontology.org/ontology/MESH/C548174 http://purl.bioontology.org/ontology/MESH/C069154 http://purl.bioontology.org/ontology/MESH/C517202 |
|
MDA |
19990101 |
|
MMR |
20170524 |
|
MN |
D03.132.052.500 D03.633.100.079.525 |
|
notation |
D005702 |
|
PA |
D010277 D002800 D018697 |
|
prefLabel |
Galantamine |
|
RR |
MJ4PTD2VVW 1953-04-4 (HBr) 357-70-0 (Galantamine) |
|
TERMUI |
T017231 T753244 T017234 T017233 T017232 T525275 T439242 T017235 T360503 |
|
TH |
USAN (2000) NLM (2002) NLM (1999) FDA SRS (2014) UNK (19XX) INN (19XX) NLM (2010) |
|
tui |
T109 T121 |
|
subClassOf |